Founder, Director, CTO, Astra
Adam London is Founder, Director, and CTO of Astra (NASDAQ: ASTR), where he leads Astra's technology development and long-term product strategy. Prior to Astra, he co-founded Ventions where he led technology development efforts of miniature rocket technologies in partnership with NASA and DARPA. Previously, Adam spent four years with McKinsey & Company, serving clients in numerous industries on strategic, manufacturing, and product development topics. Adam has a B.S., M.S., and Ph.D. in Aerospace Engineering from MIT where his research culminated in the creation of the world’s first liquid-cooled chemical rocket engine made from single-crystal silicon. Adam lives in San Francisco.Close Bio
Founder, Bramalea Partners
Andrew Boyd is the founder of Bramalea Partner. Former Head of Global Equity Capital Markets at Fidelity Investments, where he leads the private equity investments across the Fidelity funds. In this role he has been a forefront of technology development, as a leading investor in firms such as Uber, Snapchat and SpaceX. Before joining Fidelity, Andrew was an attorney at Goodwin Proctor LLP and a partner at Davies Ward LLP. Andrew Boyd earned his bachelor of laws from the University of Windsor, and his juris doctorate degree from the University of Detroit.Close Bio
Rent-a-Director, Corporate Marketing and Communications
After graduating from the UW – Madison, Anne headed to California to be part of Silicon Valley ‘s innovative environment, joining Intel in 1982. While at Intel, Anne managed the advertising, public relations, and tradeshows for the microprocessor division. She then joined fellow Intel colleagues at a start-up and realized this was her passion. Following the public offering of the start-up, Anne was asked by various venture firms to provide services for their portfolio companies, operating as a Rent-A-Director, Corporate Marketing and Communications. Anne has launched 26 start-ups, from Shutterfly to NVIDIA. With a newfound passion for sustainability and a desire to reduce the embodied carbon of the built environment, Anne has turned her engagements to architects, general contractors, innovative materials suppliers, and tech companies delivering pathways to low carbon concrete. During these engagements, Anne engages like an in-house team member, developing compelling communications programs, based on memorable positioning and key program elements from logo, brand and website development, launch strategies, PR, and much more.Close Bio
CMO, PillPack / Amazon Pharmacy
Colin Raney is the Chief Marketing Officer of PillPack. Prior to PillPack, he served as CMO of Formlabs a 3D printing company founded at the MIT Media Lab. He also spent 8-years at IDEO, serving as the Managing Director of IDEO Boston and an Associate Partner within the firm. At IDEO, Raney helped to pioneer the Business Design discipline, which uses design methodologies to develop new business ventures. He has written for the Harvard Business Review and Fast Company. He holds an MBA from Carnegie Mellon.Close Bio
VP, XL Grid
Colleen Calhoun serves as the Vice President and General Manager of XL Grid. Most recently Colleen has been an advisor to Commonwealth Fusion, Quaise Inc and several other corporations helping them grow and scale energy-focused businesses. She is a member of the Board of Directors for Quaise, Inc. Evergreen Climate Innovations (f.k.a Clean Energy Trust) and Nabors Energy Transition Corp. Colleen spent twenty-five years at GE across several roles at the company including head of GE Energy Ventures, leader of Marketing & Strategy for GE’s Power & Water business and head of the Global Growth Markets platform for Energy Financial Services. Colleen was a senior member of the team that launched Current, powered be GE, a leading provider of energy efficiency and digital productivity solutions for commercial buildings and cities. She served as the Chief Marketing Officer and head of Business Development of GE Current and was instrumental in the divesture of the business from GE in 2019. Colleen earned her bachelor’s degree in engineering from the University of Pennsylvania and an MBA from the University of Michigan.Close Bio
CTO & Co-Founder, Ambri
David co-founded Ambri, a spin-out company from MIT based on his Masters and PhD thesis work, to develop and commercialize the ‘Liquid Metal Battery’ technology, with a focus on creating a low-cost, safe, and long-lifespan storage technology for grid-scale energy storage applications. David has led a wide array of company functions since its founding, including product roadmapping, budgeting, fundraising, team building, cell development, systems engineering, manufacturing, HR, EHS & facilities, and IP. Presently, David is part of Ambri’s executive leadership team, focused on Cell Development and Applied Research. The company has raised over $200M in funding, including funding from Bill Gates, Reliance New Energy Solar, Paulson & Co, and others.
David earned a BSc in Engineering Physics from Queen's University, and an MEng and a PhD in Materials Science and Engineering from the Massachusetts Institute of Technology. In 2010, he received a TR35 award for being a top innovator under 35 from Technology Review magazine.Close Bio
Americas Regional VP of Engineering & Project Management, Fluence Energy
Dax is the Americas Regional Vice President of Engineering & Project Management at Fluence Energy (TICKR: FLNC). As a member of the Fluence founding team in 2018 Dax integrated the global technical sales & project execution functions post-merger between AES Energy Storage & Siemens Energy Storage. From 2018-2020 he led and built these functions to scale from 80 MW in 2017 to over 2,000 MW in 2020, helping Fluence to achieve unicorn status. Dax earned his PhD in Engineering Sciences from the Thayer School of Engineering at Dartmouth where he also co-founded SustainX, one of the first grid-scale energy storage start-ups. As the founding CEO he raised investment capital from blue-chip venture capital investors, forged strategic partnerships, and led cross-functional teams through product development. The company ultimately merged with General Compression, to form GCX.Close Bio
CEO, Motif FoodWorks
Dr. Jonathan McIntyre, Ph.D., joined Motif FoodWorks in February 2019 as Chief Executive Officer and member of the board of directors. Motif is a Boston-based food-technology company focused on unleashing the promise of plant-based foods by making them better tasting, more nutritious and so desirable that people crave them. Motif partners with food and nutrition companies of all sizes and is pioneering a ‘whole science’ approach that combines insights and technology in novel ways to get new, better answers, benefiting everyone and our planet.
Prior to joining Motif, Dr. McIntyre served as Head of Research and Development at Indigo Agriculture, Inc. In this role Dr. McIntyre was responsible for developing microbial seed treatments to replace or reduce chemical inputs and increase crop yields with desirable attributes during periods of biotic or abiotic stress. During this period Dr. McIntyre served as a Board Director for Kaleido Biosciences Inc., a clinical stage healthcare company with a differentiated, chemistry-driven approach focused on leveraging the potential of the microbiome to treat disease and improve
Previously, Dr. McIntyre served as Senior Vice President of Research & Development at PepsiCo from 2009 to 2017, driving innovation and developing products across the company’s Global Snacks and Beverage categories, leading a diverse team of food scientists, process and packaging engineers, culinary chefs, and sensory specialists. As head of beverage R&D, he led a comprehensive transformation of the product portfolio including: the complete redesign of all brand packaging (PepsiCo CSDs, Lipton, Starbucks RTD, Gatorade & Tropicana); the reformulation of Lipton Pure Leaf Tea; the launch of new fountain equipment; and the shift to lower sugar formulations across the portfolio. Similarly, as head of Global Snacks R&D, Dr. McIntyre drove important advances of PepsiCo’s sustainability programs, developing compostable thin film packaging technology; reducing salt and fat in snacks; introducing veggie- and protein-forward snacks all while expanding company’s core product portfolio.
Prior to PepsiCo, Dr. McIntyre served as Senior Vice President of Technology & Innovation at Solae, LLC, a DuPont Foods & Nutrition company, where he led R&D, quality, regulatory and technology licensing for the world’s largest plant-protein company. At Solae he focused his teams on building up novel application, improving ingredient offerings for higher margin food formulas and improving the cost structure for higher volume lower margin commodity ingredients. Prior to Solae, Dr. McIntyre served as the Senior Vice President, Product Development at Auxeris Therapeutics Inc., where he supported the development of its lead candidates for the prevention and treatment of osteoporosis and bone metastases.
Dr. McIntyre began his career at Monsanto as a discovery researcher with their Searle Pharmaceutical division, working on drugs for cardiovascular and metabolic diseases. Later, he transferred to the NutraSweet division where he led product development for new food ingredients. And he finished his time with the company as the Chief Scientist of Monsanto Protein Technologies, a contract manufacturing business using biotechnology to engineer plants to produce protein therapeutics.
Dr. McIntyre is a highly credentialed scientist, he served as a member of the Scientific Advisory Board at Anaptys Biosciences, Inc. and is a member of numerous professional societies including the American Chemical Society; Federation of American Societies for Experimental Biology; American Society for Biochemistry and Molecular Biology; American Association for the Advancement of Science. He is also a commissioner on the Council of Competitiveness, a group of corporate CEOs, university presidents and labor leaders committed to the future prosperity of all Americans and enhanced U.S. competitiveness in the global economy through the creation of high-value economic activity in the United States.
Dr. McIntyre earned his B.S. in Chemistry from Grove City College and his Ph.D. in Biochemistry from the University of Cincinnati College of Medicine. He completed post-doctoral training in Cell Biology at the University of Cincinnati College of Medicine. Dr. McIntyre currently lives in Boston and when he isn’t transforming the world of food, he enjoys finding balance through his yoga practice and experimenting in the kitchen with plant-based food creations.Close Bio
Dr. Jennifer Holmgren is CEO of revolutionary carbon recycling company, LanzaTech. Prior to joining LanzaTech, Dr. Holmgren was VP and General Manager of the Renewable Energy and Chemicals business unit at UOP LLC, a Honeywell Company. She was one of the key drivers of UOP’s leadership in low carbon aviation biofuels, and under her management, UOP technology became instrumental in producing nearly all of the initial fuels used by commercial airlines and the military for testing and certification of alternative aviation fuel. Today, under Dr. Holmgren’s guidance, LanzaTech is working towards developing a variety of platform chemicals and fuels, including the world’s first alternative jet fuel derived from industrial waste gases. Jennifer is also the Director and Chair of the LanzaJet Board of Directors. LanzaJet, Inc., is a new company that will produce sustainable aviation fuel (SAF) for a sector requiring climate friendly fuel options.
Dr. Holmgren is the author or co-author of 50 US patents and more than 30 scientific publications and is a member of the National Academy of Engineering. In 2003, she was the first woman awarded the Malcolm E. Pruitt Award from the Council for Chemical Research (CCR). In 2010, she was the recipient of the Leadership Award from the Civil Aviation Alternative Fuels Initiative (CAAFI) for her work in establishing the technical and commercial viability of sustainable aviation biofuels. In 2015 Dr. Holmgren and her team at LanzaTech were awarded the U.S. Environmental Protection Agency Presidential Green Chemistry Award and she was awarded the BIO Rosalind Franklin Award for Leadership in Industrial Biotechnology. Sustainability magazine, Salt, named Dr. Holmgren as the world’s most compassionate businesswoman in 2015. In October 2015, Dr. Holmgren was awarded the Outstanding Leader Award in Corporate Social Innovation from the YWCA Metropolitan Chicago. Dr. Holmgren was named as #1 of the 100 most influential leaders in the Bioeconomy in 2017 and received a Global Bioenergy Leadership Award in 2018 and the 2020 William C. Holmberg Award for Lifetime Achievement in the Advanced Bioeconomy by the Digest, the most widely read online bioeconomy journal. A TEDx Chicago speaker, Jennifer is also the 2018 recipient of the AIChE Fuels & Petrochemicals Division Award as well as the Biofuels Digest Global Bioenergy Leadership Award. In 2021 Jennifer received the Edison Achievement Award for making a significant and lasting contribution to the world of innovation and the Prix Voltaire Award, awarded by the Prix Voltaire International Foundation, the award is based on the 17 sustainable development goals.
She currently serves on The National Renewable Energy Laboratory (NREL) Biofuels Advisory Committee and is on the Governing Council for the Bio Energy Research Institute in India. The institute has been set up by the DBT (Department of Biotechnology, Indian Government) and IOC (Indian Oil Corporation). She was the Future Fuels Leader for the ART Fuels Forum, a group financed by the European Commission, which brings together selected representatives under the project: “Support for alternative and renewable liquid and gaseous fuels forum (policy and market issues)”. She is also on the Advisory Council for the Andlinger Center for Energy and the Environment at Princeton University and on the Halliburton Labs Advisory Board.
Dr. Holmgren holds a B.Sc. degree from Harvey Mudd College, a Ph.D. from the University of Illinois at Urbana-Champaign and an MBA from the University of Chicago.Close Bio
Chairman of the Board, Orchard Therapeutics & Pieris Pharmaceuticals
Jim Geraghty is a biotech industry leader with 40 years of strategic leadership experience, including 30 years with biotech companies developing and commercializing innovative therapies. Jim serves today as chairman of the boards of Orchard Therapeutics and Pieris Pharmaceuticals, and on the boards of Voyager Therapeutics, Fulcrum Therapeutics, and Idera Pharmaceuticals. Jim was from 2013-2016 an entrepreneur-in-residence at Third Rock Ventures, a leading biotech venture and company formation fund. He previously served as senior vice president, North America strategy and business development at Sanofi, which he joined upon its acquisition of Genzyme. Jim spent over 20 years at Genzyme, where his roles included senior vice president of international development, president of Genzyme Europe, general manager, cardiovascular, and founding president and CEO of Genzyme Transgenics Corporation. Jim started his career in healthcare strategy consulting at Bain and Company. A graduate of the Yale Law School, Jim also holds an M.S. from the University of Pennsylvania and a B.A. from Georgetown UniversityClose Bio
Global Healthcare Executive
Dr. Martin D. Madaus is a serial global healthcare CEO, board member, investor and strategy consultant with over 30 years of experience in the Diagnostics and Life Science Tools Industry. He has a track record for delivering outstanding results by transforming large and complex business. He current works for The Carlyle Group as an Operating Executive and serves as Chairman of Ultivue, Inc., Emulate Bio, Director at Unchained Labs, Lead Director at Quanterix Corporation (QTRX) and Director at Candela Medical.
He was Chairman and Chief Executive Officer at Ortho-Clinical Diagnostics, Inc. (OCD) from June 2015 until February of 2019 leading the carve-out from JNJ and the business turnaround.
Prior to joining Ortho, Dr. Madaus served as Executive Chairman of Quanterix Corporation, and as Senior Healthcare Advisor to the Carlyle Group.
He was Chairman, President and Chief Executive Officer of Millipore Corporation (NYSE: MIL) from January 2005 to July 2010. In addition, Dr. Madaus was President and Chief Executive Officer of Roche Diagnostics Corporation North America from 2000 to 2004. Prior to that, he served as Vice President of Business Development for Roche Molecular Diagnostics, and served as the President of Roche Diagnostics Canada.
Dr. Madaus started his career in the Diagnostics Industry in 1989 at Boehringer Mannheim, Germany and served in various product management, marketing and general management roles in Germany, the United States and Canada.
Dr. Madaus has extensive public and private company board experience and has served on the board of Mettler-Toledo International Inc. (NYSE: MTD), Covidien PLC (NYSE: COV), Millipore (NYSE:MIL), PPD International, Quanterix (NASDAQ: QTRX), Candela Medical, Ultivue Inc., Emulate Bio.
Dr. Madaus received a Doctor of Veterinary Medicine degree from the University of Munich in Germany and a PhD in Veterinary Medicine from the Veterinary School of Hanover in Germany.Close Bio
CEO & Founder, Kiva Systems
Kiva System’s order-fulfillment solution deploys hundreds-of-thousands of mobile robots into ecommerce pick-pack-and-ship fulfillment centers and kicked-off the wave of robotics automation now sweeping the material handling world.
Mick founded Kiva in January 2003 after spending time in high-tech product development, manufacturing and marketing at Motorola, Apple, and Webvan. In 2009 under Mick’s leadership Kiva was ranked #6 on the Inc. 500 list of the fastest growing private companies in America, and in 2012 Fast Company recognized Kiva as the 23rd Most Innovative Company in the World. That same year, Amazon.com acquired Kiva and later renamed the unit Amazon Robotics. Mick holds over 40 U.S. technology patents and is a member of the National Inventors Hall of Fame. He earned a BS in mechanical engineering from MIT and an MBA from Harvard and is now an active Boston-area technology advisor and seed investor working with innovative hardware-based startups.Close Bio
Co-Founder & CPO, Artificial
Nikhita Singh is the Chief Product Officer (CPO) and Co-Founder of Artificial. As CPO, Nikhita spearheads the product strategy and development of Artificial, a first-of-its-kind lab automation platform that lowers the barrier of adopting automation so labs can accelerate their next breakthrough.
Before Artificial, Nikhita was a researcher at the Personal Robots Group at the MIT Media Lab where she designed and studied socially intelligent robots and AI platforms. Nikhita also drove product at Palantir for several Fortune 500 companies and government agencies in the US and Europe. She received her M.S. in Media Arts & Science from the Massachusetts Institute of Technology and her B.S. in Industrial Engineering and Operations Research from the University of California-BerkeleyClose Bio
Senior Partner, McKinsey and Company
Paul is a Senior Partner at McKinsey and Company where his focus is on global energy and natural resources. He was a former global leader of McKinsey’s energy and materials practice, working in McKinsey’s Houston, Austin, London and Hong Kong offices. His clients span international energy companies, state-owned enterprises, mid-cap growth companies and private equity. He has served clients across North America, Europe, Middle East, West Africa and Asia on growth topics, including market entry and technology strategy, new business building, performance transformation, and M&A. Prior to McKinsey, Paul was a tenured Associate Professor of Mechanical Engineering at UC Berkeley, where he was part of the manufacturing group. Paul received his S.B., S.M. And PhD degrees in mechanical engineering from MIT.Close Bio
Board Chair, FirstLight & US Secretary of Energy Advisory Board
Phil has 45 years’ experience in the energy industry as a geologist, consultant, entrepreneur, executive, board director and energy official in state and federal roles. Phil is the Board Chair for FirstLight and serves on the US Secretary of Energy Advisory Board. Previously he served as Special Assistant to the President for Climate Policy. Phil was CEO, executive and/or board member for several energy innovation startups including Ambri (formerly Liquid Metal Battery Corporation), EnerNOC (now EnelX), FirstFuel (now Uplight), and Nexus (now Aclara). He has also been a board member for the Northeast Clean Energy Council, Prime Coalition, Clean Air Task Force and was Massachusetts Energy Undersecretary and Commissioner. He was founding board member, Treasurer and Vice Chair for the Regional Greenhouse Gas Initiative (RGGI), board chair National Association of Energy Officials as well as DOE’s State Energy Advisory Board, Energy Efficiency and Renewables Advisory Committee and EPA/DOE’s State Energy Efficiency Action Network. He has an MBA from the Tuck School at Dartmouth College, a Master of Science (economic geology) from the University of Arizona and a Bachelor of Science (geology) from the University of New Hampshire.Close Bio
Prescott began his career in healthcare at Baxter International before spending over a decade scaling businesses at GE where he served as General Manager of a wind turbine components business and then as founder-CEO of a standalone battery energy storage startup. After GE, Prescott held both turnaround and startup assignments, first as divisional President of a PE-owned waterjet business, and then as Commercial Head of a VC-backed, agtech startup where he helped build a multi-sided grain marketplace.
Prescott’s professional foundation in sales, marketing, product management, and P&L management have grounded him in the operational rigor required to lead profitable industrial technology manufacturing businesses. But his passion lies in scaling early-stage, hard-tech ventures with the potential to do good. Prescott graduated from Yale and holds an MBA from the Kellogg School of Management.Close Bio
Founder & CEO, Malta
Ramya Swaminathan led the spin-out of Malta from X, Alphabet's Moonshot Factory (formerly Google X) in 2018 and has been the company’s CEO since its founding. She has led Malta through multiple rounds of corporate venture funding and has recruited a multi-disciplinary team focused on commercializing Malta’s thermal storage technology. She currently serves as a US Department of Energy Clean Energy Education and Empowerment (C3E) Ambassador. She was appointed by the US Secretary of Energy Jennifer Granholm to the Electricity Advisory Committee (EAC) to advise the Department of Energy on modernizing the nation’s electricity delivery infrastructure and was appointed by the US Secretary of Commerce Gina Raimondo to the Renewable Energy and Energy Efficiency Committee (REEAC) to advise the Commerce Department on US competitiveness in these sectors. She was also named a Business Insider’s 2020 list of 21 Rising Stars in clean energy.
Before founding Malta as an independent company, Ramya was the CEO of Rye Development, a hydropower development firm that she grew to be the leading developer of new hydropower projects in the United States. She was responsible for the expansion of Rye’s platform into energy storage, with the addition of two sizable pumped storage hydro development projects in the U.S. Pacific Northwest. Prior to her work in the hydropower space, she was a public finance banker, most recently as a Director at UBS where she focused on public power clients and senior managed more than $10 billion in financings. She holds a Master’s in Public Policy from the Harvard John F. Kennedy School of Government and a BA in Anthropology from Amherst College.Close Bio
Inventor & Entrepreneur
Stan Lapidus is an inventor and entrepreneur who currently serves on a number of healthcare and medical technology boards.
He’s been founding CEO of three medical diagnostics companies. Two of them have been among the most successful diagnostics startups of all time:
Cytyc Corp., which he founded in 1987, revolutionized early detection of cervical cancer through its development of the modern Pap test—the ThinPrep. The two ThinPrep prototypes are at the Smithsonian’s American Museum of National History.
EXACT Sciences, which he founded in 1995, pioneered non-invasive early detection of colorectal cancer through its Cologuard test. Since its introduction, Cologuard has become the fastest growing test in the history of the diagnostics industry.
Stan holds 37 patents, primarily in methods for early detection of cancer. He was elected as a Fellow of the American Institute of Medical and Biological Engineering in 2014 for his work on the early detection of cancer. He also served as an instructor at MIT from 2001 to 2017.
Stan graduated from Cooper Union in New York City with a BS degree in electrical engineering.Close Bio